APTO
Aptose Biosciences, Inc.
APTO
APTO
Delisted
APTO was delisted on the 1st of April, 2025.
64 hedge funds and large institutions have $277M invested in Aptose Biosciences, Inc. in 2020 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 32 increasing their positions, 11 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
22% more capital invested
Capital invested by funds: $227M → $277M (+$50.7M)
10% more funds holding
Funds holding: 58 → 64 (+6)
Holders
64
Holding in Top 10
5
Calls
$1.55M
Puts
$135K
Top Buyers
| 1 | +$12.4M | |
| 2 | +$8M | |
| 3 | +$6.19M | |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$6.18M |
| 5 |
CCM
Consonance Capital Management
New York
|
+$6.15M |
Top Sellers
| 1 | -$7.99M | |
| 2 | -$4.73M | |
| 3 | -$708K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$687K |
| 5 |
Two Sigma Investments
New York
|
-$353K |